Table 1.

Clinicopathological features of 5 cases

	Sex/Age	Interval*	Location and size of liver tumor(s)	Imaging findings (on first presentation of liver lesions)	Serum AFP level	Treatment for metastasis	Follow up (follow-up period)†
1	M/35	5 yrs	Right lobe/ 2.2 cm	CT: suspicious of HCC or HCA	Normal	Chemotherapy	AWD (34 mo) ‡
2	F/51	19 yrs	Left lobe/18 cm	CT: suspicious of HCC or HCA	Normal	Surgical resection	ANED (26 mo)
3	M/60	16 yrs	Left lobe/10 cm	CT: suspicious of HCC	Normal	Surgical resection	ANED (39 mo)
4	F/31	7 yrs	Right lobe/6 cm and 18 cm	N.A.	N.A.	Surgical resection and radioafrequency ablation	AWD (36 mo)‡
5	M/48	12 yrs	Dome/4.6 cm and 1.6 cm	N.A.	N.A.	Radiofrequency ablation	DOD (36 mo)

AFP, alpha-fetoprotein; CT, computer topography; HCC, hepatocellular carcinoma; HCA, hepatocellular adenoma; AWD, alive with disease; ANED, alive with no evidence of disease; N.A., not available; DOD, died of disease.

^*Interval from diagnosis of primary meningeal HPC to hepatic metastasis.

^†Duration from diagnosis of hepatic metastasis to last follow-up.

^‡Lost follow-up at time of review.